Publications
This section collects the most significant scientific contents of EGOI-PCOS members concerning the use of inositols alone or in association, both in basic research and for clinical application.
Also, the most relevant and updated literature on diagnosis and therapy of PCOS is gathered.
In particular, this collection includes the most recent original articles, clinical trials, reviews and meta-analyzes on the use of inositols especially in the gynecological, reproductive, metabolic, and endocrine fields.
Manuscripts inserted deal with important issues such as Polycystic Ovary Syndrome (PCOS), metabolic syndrome, insulin resistance, gestational diabetes with its complications, neurological defects for the unborn children linked to the nutritional deficiencies of mothers.
Ovulation Induction With Myo-Inositol Alone and in Combination With Clomiphene Citrate in Polycystic Ovarian Syndrome Patients With Insulin Resistance
Authors: Zdravko Kamenov, Georgi Kolarov, Antoaneta Gateva, Gianfranco Carlomagno, Alessandro D. Genazzani
Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS
Authors: Vittorio Unfer, Gianfranco Carlomagno, Enrico Papaleo, Simona Vailati, Massimo Candiani, Jean-Patrice Baillargeon
The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients
Authors: M. Minozzi, M. Nordio, R. Pajalich
Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials
Authors: V. Unfer, G. Carlomagno, G. Dante, F. Facchinetti
The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
Authors: M. Nordio, E. Proietti